MARCIE SCHUSTER: Open Payments
NPI 1902135650 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$609 in 18 payments from 10 companies in 2025. Trend: 2023 $342 · 2024 $264 · 2025 $609
Food & beverage: $609
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $245 |
| ABBVIE INC. | 3 | $87 |
| PFIZER INC. | 4 | $83 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| ARRAY BIOPHARMA INC | 1 | $17 |
| BeOne Medicines USA, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $15 |
Products named: IMFINZI, DATROWAY, IBRANCE, EPKINLY, LUTATHERA, KISQALI, OJJAARA, KEYTRUDA.
Industry payments across GA — which companies pay providers there.
